Lumicera Health Services announced today it will be participating in LEO Pharma’s Limited Distribution Network to dispense Anzupgo® (delgocitinib) Cream, the first and only FDA-approved treatment for moderate-to-severe Chronic Hand Eczema (CHE) in adults.
Lumicera and HealthBeacon are thrilled to announce a new strategic collaboration. This partnership brings together Lumicera’s expertise in specialty pharmacy services and HealthBeacon’s leadership in digital health to improve outcomes for patients on injectable therapies, one dose at a time.
Eric Huckins discusses enhancing specialty pharmacy programs in health systems by addressing challenges like 340B, payer access, and accreditation. He emphasizes the importance of strategic partnerships, biosimilars, and technology in improving patient care and fostering growth.
In his latest article highlighted in the ACHE-WI newsletter, our Vice President of Business Development, Eric Huckins, shares actionable insights we’ve used to help health systems unlock their specialty pharmacy’s full potential.
Arkansas’s Act 624 to ban PBMs from owning pharmacies is being framed as a win for independent pharmacies. But what happens when legislation targets ownership structure instead of business practices?
Eric Huckins, our Vice President of Business Development, sat down with Todd Eury of the Pharmacy Podcast Network during Asembia to share his insights on specialty pharmacy.
This July, Lumicera Specialty Pharmacy will be competing as a team in the Arthritis Foundation’s annual Jingle-in-July run, walk, or bike race!
Sharon Faust and Gina Guinasso, sat down with Todd Eury of the Pharmacy Podcast Network during Asembia to share their insights on Specialty Pharmacy.
We are very excited to announce we have been selected as part of the limited specialty network for MAVENCLAD (cladribine), a prescription medicine used to treat relapsing forms of multiple sclerosis (MS).
We see strong results negotiating directly with drug manufacturers and implementing the cost-plus model to help reduce costs for patients.
